{"ticker": {"uuid": "d5a08dc0-739a-4123-8130-97239fe61f34", "symbol": "EXOZ", "name": "eXoZymes, Inc.", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T18:49:22+00:00", "published_display": "16 Jul 2026 18:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T07:00:00+00:00", "published_display": "13 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "eXoZymes (NASDAQ: EXOZ) raises $639K in unit sale with resettable warrants", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxPOXJnbkhxOW9ZQXkyQW43NzlDaTFoQjdhQ3pvd3RsTFVER0VSS2huU0NlNTB2S0pPSnhkNWxmUWhuclhZd3FidXZjNFRHOUplekhCTzlpUnB4c3kweFdvU1FLN2l6ZWVkTUN2TWFiZEZMa1dZQ0QyLS11X05VZzgwR09fS3Bzdzlfb1pfeXBHbGwxMWY1U0xqRmpfVEEyWmE4VDBr?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "eXoZymes (NASDAQ: EXOZ) closes $5.95M stock and warrant unit offering", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxPVHlrNy10YUEzal9jcm5SR2VKT0l0QVB2blRrdFFiTXU2Ylo2RjNpdVZmekNLRkh5S2VjZWNmYllKZWJGQWRoaFI3SEZnM0JkMnNweWdtRk1sZDdoWF94YTEtR21zdjd0NEdoTkNSVTBJQ080bjVCUkN4Yi1jSGdMbThSVzJfR01fQnBXODlIM0VOamh4QXBybTBYd1hCdWZvakxz?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxOWWM3V1pmZzdlY1llRTljQmNLQ2UwdDdQaFVEcng2WVdrNE9qNzRrNVpBVlJNMGltQUhBUG1qellCVHNiM09fUkFHRW1kMEpvazJoLU11N3c4YnlWUXpmVl82aWNKeTA4U1RwSHNNSVd4d0lwWHRJclQ2TGNHWUpBQTgzbTBMVk05VGxYN0RwcmpTYklOQUFSWDhsSHZlQVpndmlPRGNvTmRmeHNILWg4ZE5jMjRoN01XNENiaVU2UDUyOWJfYUZCTm5URmtwTHJsTjJYNHo3RkxsQjBSMnBmdVZVWkFwN2PSAewBQVVfeXFMT3htM016bEt0TTdyOXE2amppMGpubTNfOFU4cGpxd2dFZkJDTjR3c0ZqOHpHYWZoamNLdmkxVmNYNklxTEM4NTU0bDZwUTZ1SW5Jc1c4NmRJN3lKQUVqUUNYYWptd2ZYNE9TeEhMRzFvbEt0bjk1TVhyVG44UnJnNDllTlFsalJVUTZwcEEzWXljbzdaQXdWWDlHQW56bGxqeG90UlFmaFFLekJlUlNIOVE4SGNHcE9pOW1KSllleVdwNERiaVl2NmxtNTNyaUtnSFY1VHUzcDJsWE9xb3R1ajZ2RGhkXzJzTldMOVA?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "We Think eXoZymes (NASDAQ:EXOZ) Needs To Drive Business Growth Carefully", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-11-13T08:00:00+00:00", "published_display": "13 Nov 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IZTC Stock Price, News & Analysis", "summary": "Invizyne Technologies (IZTC), initially known for its cell-free, enzyme-based biomanufacturing technology, has since rebranded to eXoZymes Inc. and changed its NASDAQ ticker to EXOZ. The company focuses on developing AI-engineered enzymes (\"exozymes\") for sustainable production o", "url": "https://www.stocktitan.net/overview/IZTC/", "source_name": "Stock Titan", "published_at": "2025-04-25T23:51:42", "published_display": "25 Apr 2025 23:51", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "eXoZymes, Inc. (EXOZ) Leadership & Management Team Analysis", "summary": "This article provides an analysis of eXoZymes, Inc. (EXOZ) leadership and management team. It details the CEO's compensation and tenure, along with an overview of the management team and board of directors, including their average tenure and ownership stakes. The report also incl", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-exoz/exozymes/management", "source_name": "Simply Wall Street", "published_at": "2025-02-13T18:08:56", "published_display": "13 Feb 2025 18:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "EXOZ Stock Price and Chart \u2014 NASDAQ:EXOZ", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTE1CcEx3SnFVcGpCQ3I1RmVld1BsX2UxeTVCYTNVWV81M0N5SGlSVUtCbG5xZVZnOUVIUmh1WndWeVVqSGlNNzlSY21nVU9UbTFWSnIzZ08xUHRpWERu?oc=5", "source_name": "TradingView", "published_at": "2025-02-12T18:33:53+00:00", "published_display": "12 Feb 2025 18:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rebranding Invizyne to eXoZymes Signifies a Sustainable Paradigm Shift in Chemical Production Leveraging AI-Engineered Enzymes", "summary": "Invizyne Technologies, Inc. has rebranded to eXoZymes Inc., signaling a shift towards sustainable chemical production using AI-engineered enzymes. The company's NASDAQ ticker will change from IZTC to EXOZ. This move introduces \"exozymes\" as a new scientific concept, representing ", "url": "https://kdvr.com/business/press-releases/globenewswire/9357261/rebranding-invizyne-to-exozymes-signifies-a-sustainable-paradigm-shift-in-chemical-production-leveraging-ai-engineered-enzymes/", "source_name": "FOX31 Denver", "published_at": "2025-02-12T08:50:00", "published_display": "12 Feb 2025 08:50", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Invizyne Technologies rebrands as eXoZymes with new ticker EXOZ By Investing.com", "summary": "Invizyne Technologies, Inc., a biomanufacturing firm specializing in enzyme-based systems, has rebranded as eXoZymes, Inc. The company will trade under the new ticker symbol EXOZ, expected to be effective February 12, 2025, pending approvals. This change reflects its strategic fo", "url": "https://uk.investing.com/news/company-news/invizyne-technologies-rebrands-as-exozymes-with-new-ticker-exoz-93CH-3916516", "source_name": "Investing.com UK", "published_at": "2025-02-10T16:06:00", "published_display": "10 Feb 2025 16:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Invizyne Technologies Announces Name Change To EXoZymes", "summary": "Invizyne Technologies is changing its corporate name to eXoZymes, Inc., with trading under the new ticker symbol \"EXOZ\" expected to begin on February 12, 2025. The company specializes in cell-free, enzyme-based biomanufacturing systems for creating valuable biochemicals like Acti", "url": "https://www.nasdaq.com/articles/invizyne-technologies-announces-name-change-exozymes", "source_name": "Nasdaq", "published_at": "2025-02-10T13:06:00", "published_display": "10 Feb 2025 13:06", "sentiment": "positive", "sentiment_pct": 63, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Invizyne Technologies rebrands as eXoZymes with new ticker EXOZ", "summary": "Invizyne Technologies, a company focused on enzyme-based biomanufacturing, has rebranded as eXoZymes, Inc. The company will trade under the new ticker symbol EXOZ, expected to be effective on February 12, 2025, pending approvals. This change reflects the company's strategic focus", "url": "https://www.investing.com/news/company-news/invizyne-technologies-rebrands-as-exozymes-with-new-ticker-exoz-93CH-3859728", "source_name": "Investing.com", "published_at": "2025-02-10T11:05:00", "published_display": "10 Feb 2025 11:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Invizyne Technologies Announces Name Change to eXoZymes, Inc. and New Ticker Symbol", "summary": "Invizyne Technologies, Inc. announced its corporate name change to eXoZymes, Inc. and applied for a new ticker symbol. The company expects to begin trading under the ticker symbol \"EXOZ\" on February 12, 2025, pending final approvals. Existing shareholders do not need to take any ", "url": "https://www.globenewswire.com/news-release/2025/02/10/3023585/0/en/Invizyne-Technologies-Announces-Name-Change-to-eXoZymes-Inc-and-New-Ticker-Symbol.html", "source_name": "GlobeNewswire", "published_at": "2025-02-10T11:00:00", "published_display": "10 Feb 2025 11:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "eXoZymes (NASDAQ: EXOZ) raises $639K in unit sale with resettable warrants", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxPOXJnbkhxOW9ZQXkyQW43NzlDaTFoQjdhQ3pvd3RsTFVER0VSS2huU0NlNTB2S0pPSnhkNWxmUWhuclhZd3FidXZjNFRHOUplekhCTzlpUnB4c3kweFdvU1FLN2l6ZWVkTUN2TWFiZEZMa1dZQ0QyLS11X05VZzgwR09fS3Bzdzlfb1pfeXBHbGwxMWY1U0xqRmpfVEEyWmE4VDBr?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "eXoZymes (NASDAQ: EXOZ) closes $5.95M stock and warrant unit offering", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxPVHlrNy10YUEzal9jcm5SR2VKT0l0QVB2blRrdFFiTXU2Ylo2RjNpdVZmekNLRkh5S2VjZWNmYllKZWJGQWRoaFI3SEZnM0JkMnNweWdtRk1sZDdoWF94YTEtR21zdjd0NEdoTkNSVTBJQ080bjVCUkN4Yi1jSGdMbThSVzJfR01fQnBXODlIM0VOamh4QXBybTBYd1hCdWZvakxz?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "We Think eXoZymes (NASDAQ:EXOZ) Needs To Drive Business Growth Carefully", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-11-13T08:00:00+00:00", "published_display": "13 Nov 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IZTC Stock Price, News & Analysis", "summary": "Invizyne Technologies (IZTC), initially known for its cell-free, enzyme-based biomanufacturing technology, has since rebranded to eXoZymes Inc. and changed its NASDAQ ticker to EXOZ. The company focuses on developing AI-engineered enzymes (\"exozymes\") for sustainable production o", "url": "https://www.stocktitan.net/overview/IZTC/", "source_name": "Stock Titan", "published_at": "2025-04-25T23:51:42", "published_display": "25 Apr 2025 23:51", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "eXoZymes, Inc. (EXOZ) Leadership & Management Team Analysis", "summary": "This article provides an analysis of eXoZymes, Inc. (EXOZ) leadership and management team. It details the CEO's compensation and tenure, along with an overview of the management team and board of directors, including their average tenure and ownership stakes. The report also incl", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-exoz/exozymes/management", "source_name": "Simply Wall Street", "published_at": "2025-02-13T18:08:56", "published_display": "13 Feb 2025 18:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "EXOZ Stock Price and Chart \u2014 NASDAQ:EXOZ", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTE1CcEx3SnFVcGpCQ3I1RmVld1BsX2UxeTVCYTNVWV81M0N5SGlSVUtCbG5xZVZnOUVIUmh1WndWeVVqSGlNNzlSY21nVU9UbTFWSnIzZ08xUHRpWERu?oc=5", "source_name": "TradingView", "published_at": "2025-02-12T18:33:53+00:00", "published_display": "12 Feb 2025 18:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rebranding Invizyne to eXoZymes Signifies a Sustainable Paradigm Shift in Chemical Production Leveraging AI-Engineered Enzymes", "summary": "Invizyne Technologies, Inc. has rebranded to eXoZymes Inc., signaling a shift towards sustainable chemical production using AI-engineered enzymes. The company's NASDAQ ticker will change from IZTC to EXOZ. This move introduces \"exozymes\" as a new scientific concept, representing ", "url": "https://kdvr.com/business/press-releases/globenewswire/9357261/rebranding-invizyne-to-exozymes-signifies-a-sustainable-paradigm-shift-in-chemical-production-leveraging-ai-engineered-enzymes/", "source_name": "FOX31 Denver", "published_at": "2025-02-12T08:50:00", "published_display": "12 Feb 2025 08:50", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Invizyne Technologies rebrands as eXoZymes with new ticker EXOZ By Investing.com", "summary": "Invizyne Technologies, Inc., a biomanufacturing firm specializing in enzyme-based systems, has rebranded as eXoZymes, Inc. The company will trade under the new ticker symbol EXOZ, expected to be effective February 12, 2025, pending approvals. This change reflects its strategic fo", "url": "https://uk.investing.com/news/company-news/invizyne-technologies-rebrands-as-exozymes-with-new-ticker-exoz-93CH-3916516", "source_name": "Investing.com UK", "published_at": "2025-02-10T16:06:00", "published_display": "10 Feb 2025 16:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Invizyne Technologies Announces Name Change To EXoZymes", "summary": "Invizyne Technologies is changing its corporate name to eXoZymes, Inc., with trading under the new ticker symbol \"EXOZ\" expected to begin on February 12, 2025. The company specializes in cell-free, enzyme-based biomanufacturing systems for creating valuable biochemicals like Acti", "url": "https://www.nasdaq.com/articles/invizyne-technologies-announces-name-change-exozymes", "source_name": "Nasdaq", "published_at": "2025-02-10T13:06:00", "published_display": "10 Feb 2025 13:06", "sentiment": "positive", "sentiment_pct": 63, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Invizyne Technologies rebrands as eXoZymes with new ticker EXOZ", "summary": "Invizyne Technologies, a company focused on enzyme-based biomanufacturing, has rebranded as eXoZymes, Inc. The company will trade under the new ticker symbol EXOZ, expected to be effective on February 12, 2025, pending approvals. This change reflects the company's strategic focus", "url": "https://www.investing.com/news/company-news/invizyne-technologies-rebrands-as-exozymes-with-new-ticker-exoz-93CH-3859728", "source_name": "Investing.com", "published_at": "2025-02-10T11:05:00", "published_display": "10 Feb 2025 11:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Invizyne Technologies Announces Name Change to eXoZymes, Inc. and New Ticker Symbol", "summary": "Invizyne Technologies, Inc. announced its corporate name change to eXoZymes, Inc. and applied for a new ticker symbol. The company expects to begin trading under the ticker symbol \"EXOZ\" on February 12, 2025, pending final approvals. Existing shareholders do not need to take any ", "url": "https://www.globenewswire.com/news-release/2025/02/10/3023585/0/en/Invizyne-Technologies-Announces-Name-Change-to-eXoZymes-Inc-and-New-Ticker-Symbol.html", "source_name": "GlobeNewswire", "published_at": "2025-02-10T11:00:00", "published_display": "10 Feb 2025 11:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T18:49:22+00:00", "published_display": "16 Jul 2026 18:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T07:00:00+00:00", "published_display": "13 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 87, "total_relevant": 20, "sentiment_summary": {"positive": 7, "negative": 1, "neutral": 12, "score": 57, "total": 20, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 80, "events": [{"event": "general", "label": "Market update", "weight": 5.5, "count": 10}, {"event": "earnings", "label": "Earnings", "weight": 3.71, "count": 9}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}], "positive_events": 7, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 6.02, "latest_week": "2026-07-17", "one_week_move": -13.6, "four_week_move": -23.1, "twelve_week_move": -41.6, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.304417, "market_dynamics_buy_signal": false, "relative_strength": -49.936197, "fair_value_gap": -49.0, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 40.1099, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-13.6% over one week, -23.1% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 66, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 6}, {"label": "Stock Titan", "count": 3}, {"label": "simplywall.st", "count": 3}, {"label": "TradingView", "count": 2}, {"label": "Simply Wall Street", "count": 1}, {"label": "FOX31 Denver", "count": 1}, {"label": "Investing.com UK", "count": 1}, {"label": "Nasdaq", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 11}, {"label": "Industry context", "count": 9}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 10}, {"label": "Earnings", "count": 9}, {"label": "Guidance", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "57/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "80/100 classification confidence."}, {"label": "Company focus", "value": "11", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-13.6% over one week, -23.1% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "eXoZymes (NASDAQ: EXOZ) raises $639K in unit sale with resettable warrants"}], "updated_at": "2026-07-23T08:43:08.613912+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}